FDA approves new use for Evista.
D017277:Drug Approval; D017320:HIV Protease Inhibitors; D006801:Humans; D020849:Raloxifene Hydrochloride; D014481:United States; D014486:United States Food and Drug Administration
D017320:HIV Protease Inhibitors; D020849:Raloxifene Hydrochloride